Take Your Profits On BioCryst Pharmaceuticals Stock

BioCryst Pharmaceuticals, Inc. has reported that the Phase 1 trial of the oral treatment BCX4161 has met all objectives.

http://seekingalpha.com/article/1668262-take-your-profits-on-biocryst-pharmaceuticals-stock?source=feed